Search results

Page results

• Outpatient Hysteroscopy

  https://www.uclh.nhs.uk/patients-and-visitors/patient-information-pages/outpatient-hysteroscopy#

• Major UCLH investment in research and training to benefit staff and patients

  A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.

• War in the Blood, a film about treating cancer patients with CAR T cell therapy

  A BBC film which looks at the work of scientists at UCL and clinicians at UCLH working together on groundbreaking ‘first in-human’ immunotherapy trials is being shown again on BBC2 tonight.

• Film aims to reassure relatives of critical care patients who cannot visit them in hospital

  A critical care nurse at The National Hospital for Neurology and Neurosurgery, Helen Burgess, has produced a short film to provide reassurance to relatives unable to visit their loved ones because of visitor restrictions during the Covid-19 pandemic.

• Navigating the exam period

  The psychology team at UCLH will be running a 'Navigating the exam period' workshop on Thursday 26 October 2023, 10am - 1pm, at UCLH. 

• Relocation of Hyperacute Stroke Unit

  The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.

• Research autopsies reveal how incurable skin cancer resists treatment

  Research conducted at UCLH has discovered how some skin cancers stop responding to treatment at the end of life.

• Omnipod 5 software update – Week commencing 15 July

  Omnipod 5 users will get a notification on their Omnipod 5 Controller to install a software update (version 2.0).

• $175.5 million for immunotherapy spin-out to develop new treatments

  Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.

• COVID-19 treatments for highest risk non-hospitalised patients

  We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.